Metabolic and endocrinological causes of dementia

International Psychogeriatrics

Volumn 17, Issue SUPPL. 1, 2005, Pages

  Flicker, Leon ^a   Ames, David ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cognitive impairment; Investigations; Tests; Thyroid disease; Vitamin deficiencies

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; DEMECLOCYCLINE; DESMOPRESSIN; GLUCOCORTICOID; MINERALOCORTICOID; NICOTINIC ACID; PRASTERONE; TRIENTINE; ZINC;

ADDISON DISEASE; AGED; ALUMINUM OVERLOAD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; CUSHING SYNDROME; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIABETES INSIPIDUS; ENDOCRINE DISEASE; FOLIC ACID DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPERNATREMIA; HYPOGLYCEMIA; HYPONATREMIA; HYPOPARATHYROIDISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; KIDNEY FAILURE; LIVER FAILURE; MARCHIAFAVA BIGNAMI DISEASE; METABOLIC DISORDER; NERVE CELL DEGENERATION; NICOTINIC ACID DEFICIENCY; OXYGEN THERAPY; PARATHYROID DISEASE; PELLAGRA; REVIEW; THYROID DISEASE; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; WILSON DISEASE; HYPERPARATHYROIDISM; METABOLISM; PATHOPHYSIOLOGY;

AVITAMINOSIS; DEMENTIA; HUMANS; HYPERNATREMIA; HYPERPARATHYROIDISM; HYPONATREMIA; LIVER FAILURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THYROID DISEASES;

EID: 33644824274     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610205001961     Document Type: Review

References (47)

1. Als-Nielsen, B., Gluud, L. L. and Gluud, C. (2004). Nonabsorbable disaccharides for hepatic encephalopathy. The Cochrane Database of Systematic Reviews, Issue 2. DOI: 10.1002/14651858.CD003044.
2. Ames, D., Flicker, L. and Helme, R. (1992). A memory clinic at a geriatric hospital: rationale, routine and review of the first 100 patients. Medical Journal of Australia, 156, 618-622.
3. Areosa Sastre, A. and Grimley Evans, J. (2003). Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. The Cochrane Database of Systematic Reviews, Issue 1. DOI: 10.1002/14651858.CD003804.
4. Belanoff, J. K., Gross, K., Yager, A. and Schatzberg, A. F. (2001). Corticosteroids and cognition. Journal of Psychiatric Research, 35, 127-145.
5. Cape, R. D. T. and Shinton, N. K. (1961). Serum vitamin B12 concentration in the elderly. Gerontologia Clinica, 3, 163-172.
6. Draelos, M. T. et al. (1995). Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. American Journal of Medicine, 98, 135-144.
7. Grant, I., Heaton, R. K., McSweeny, A. J., Adams, K. M. and Timms, R. M. (1982). Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Archives of Internal Medicine, 142, 1470-1476.
8. Griva, K. et al. (2003). Acute neuropsychological changes in hemodialysis and peritoneal dialysis patients. Health Psychology, 22, 570-578.
9. Hankey, G. J. and Eikelboom, J. W. (1999). Homocysteine and vascular disease. Lancet, 354, 407-413.
10. Hassanyeh, F., Murray, R. B. and Rodgers, H. (1991). Adrenocortical suppression presenting with agitated depression, morbid jealousy, and a dementia-like state. British Journal of Psychiatry, 159, 870-872.
11. Heaton, R. K., Grant, I., McSweeny, A. J., Adams, K. M. and Petty, T. L. (1983). Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Archives of Internal Medicine, 143, 1941-1947.
12. Hegyi, J., Schwartz, R. A. and Hegyi, V. (2004). Pellagra: dermatitis, dementia, and diarrhea. International Journal of Dermatology, 43, 1-5.
13. Heinrich, A., Runge, U. and Khaw, A. V. (2004). Clinicoradiologic subtypes of Marchiafava-Bignami disease. Journal of Neurology, 251, 1050-1059.
14. Hunt, P. J. et al. (2000). Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism, 85, 4650-4656.
15. Incalzi, R. A. et al. (2003). Cognitive impairment in chronic obstructive pulmonary disease: a neuropsychological and SPECT study. Journal of Neurology, 250, 325-332
16. Joborn, C., Hetta, J., Frisk, P., Palmer, M., Akerstrom, G. and Ljunghall, S. (1986). Primary hyperparathyroidism in patients with organic brain syndrome. Acta Medica Scandinavica, 219, 91-98.
17. Kirby, D. and Ames, D. (2001). Hyponatraemia and selective serotonin re-uptake inhibitors in elderly patients. International Journal of Geriatric Psychiatry, 16, 484-493.
18. Kowdley, K. V., Coull, B. M. and Orwoll, E. S. (1999). Cognitive impairment and intracranial calcification in chronic hypoparathyroidism. American Journal of the Medical Sciences, 317, 273-277.
19. La Rue, A., Koehler, K. M., Wayne, S. J., Chiulli, S. J., Haaland, K. Y. and Garry, P. J. (1997). Nutritional status and cognitive functioning in a normally aging sample: a 6-year reassessment. American Journal of Clinical Nutrition, 65, 20-29.
20. Leverenz, J. B. et al. (1999). Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. Journal of Neuroscience, 1, 2356-2361.
21. Lindenbaum, J. et al. (1988). Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. New England Journal of Medicine, 318, 1720-1728.
22. Malouf, R. and Areosa Sastre, A. (2003). Vitamin B12 for cognition. The Cochrane Database of Systematic Reviews, Issue 3. DOI: 10.1002/14651858. CD004394.
23. Malouf, R., Grimley Evans, J. and Areosa Sastre, A. (2003). Folic acid with or without vitamin B12 for cognition and dementia. The Cochrane Database of Systematic Reviews, Issue 4. DOI: 10.1002/14651858.CD004514.
24. Martignoni, E. et al. (1992). The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology, 17, 343-354.
25. Martin, F. I. and Deam, D. R. (1996). Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes. Medical Journal of Australia, 164, 200-203.
26. Mauri, M. et al. (1993). Memory impairment in Cushing's disease. Acta Neurologica Scandinavica, 87, 52-55.
27. McCrea, M., Cordoba, J., Vessey, G., Blei, A. T. and Randolph, C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53, 758-763.
28. Metz, J. et al. (1996). The significance of subnormal serum vitamin B12 concentration in the elderly: a case study. Journal of the American Geriatrics Society, 44, 1355-1341.
29. Munte, T. F., Radamm, C., Johannes, S. and Brabant, G. (2001). Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: a double-blind cross-over study using event-related brain potentials. Thyroid, 11, 385-391.
30. O'Brien, J. T., Ames, D., Schweitzer, I., Colman, P., Desmond, P. and Tress, B. (1996a). Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease. British Journal of Psychiatry, 168, 679-687.
31. O'Brien, J. T., Ames, D., Schweitzer, I., Mastwyk, M. and Colman, P. (1996b). Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychological Medicine, 26, 7-14.
32. Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A. and Breteler, M. M. (1999). Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology, 53, 1937-1942.
33. Palevsky, P. M., Bhagrath, R. and Greenberg, A. (1996). Hypernatremia in hospitalized patients. Annals of Internal Medicine, 124, 197-203.
34. Phillips, P. A., Bretherton, M., Johnston, C. I. and Gray, L. (1991). Reduced osmotic thirst in healthy elderly men. American Journal of Physiology, 261, R166-R171.
35. Portala, K., Levander, S., Westermark, K., Ekselius, L. and von Knorring, L. (2001). Pattern of neuropsychological deficits in patients with treated Wilson's disease. European Archives of Psychiatry and Clinical Neuroscience, 251, 262-268.
36. Prager, G. et al. (2002). Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery, 132, 930-935.
37. Riggs, K. M., Spire, A., Tucker, K. and Rush, D. (1996). Relations of vitamin B12, vitamin B6, folate and homocysteine to cognitive function in the normative aging study. American Journal of Clinical Nutrition, 63, 306-314.
38. Russell, D. M., Keller, F. S. and Whitaker, J. N. (1989). Episodic confusion and tremor associated with extrahepatic portacaval shunting in cirrhotic liver disease. Neurology, 39, 403-405.
39. Sapolsky, R., Krey, L. and McEwen, B. S. (1985). Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. Journal of Neuroscience, 5, 1222-1227.
40. Seshadri, S. et al. (2002). Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine, 346, 476-483.
41. Silver, A. J. and Morley, J. E. (1992). Role of the opioid system in the hypodipsia associated with aging. Journal of the American Geriatrics Society, 40, 556-560.
42. Sima, A. A., Kamiya, H. and Li, Z. G. (2004). Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. European Journal of Pharmacology, 490, 187-197.
43. Sprague, S. M., Corwin, H. L., Tanner, C. M., Wilson, R. S., Green, B. J. and Goetz, C. G. (1988). Relationship of aluminum to neurocognitive dysfunction in chronic dialysis patients. Archives of Internal Medicine, 148, 2169-2172.
44. Stuerenburg, H. J., Hansen, H. C., Thie, A. and Kunze, K. (1996). Reversible dementia in idiopathic hypoparathyroidism associated with normocalcemia. Neurology, 47, 474-476.
45. Trouillas, P., Brudon, F. and Saubier, M. (1985). Parathyrotoxic encephalopathy without hypercalcemia. Revue Neurologique, 141, 562-570.
46. Wahlund, L., Basun, H. and Waldemar, G. (2002). Reversible or arrestable dementias. In N. Qizilbash et al. (Eds.) Evidence-based Dementia Practice (pp. 330-340). Oxford: Blackwell Science.
47. Yoshitake, T. et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology, 45, 1161-1168.